検索結果

Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical

From eye drops to contact lens preparations-Mytear eye solutions head a diverse line of trusted products Building on a reputation for excellence in ophthalmological drugs, Senju Pharmaceutical has cul...

产品开发方针 | 研究与开发 | 千寿制药株式会社

标疾病。另外，至今为止，我们的产品开发以医疗用药品为中心，而出于以通过新形式为眼科诊疗做贡献的想法，我们也决定开发医疗器械类的产品。 在今后的各种产品开发中，我们将发挥每个人作为“Bliss Creator**”的力量和企业的最大优势“团结力”，为全世界创造和提供尽可能多的高价值产品。 *未满足的医疗需求：尚未得到满足的医疗方面的需求 ** Bliss Creator：认为自己工作的目的和意义与千...

Product Development Policy | Research & Development | SENJU Pharmaceutica

agement philosophy of “Good Company” and a company that shapes “Beyond eyesight,” we have developed products that contribute to maintenance and improvement of “a joy to behold” or QOV (Quality of Visi...

お知らせ | 千寿製薬株式会社

September 4, 2025 Senju has developed and obtained approval for a BAC-free formulation of Aibeta® combination eye drops（PDF） March 7, 2025 Announcement of Licensing Agreement with Brill International（...

承認された治療法はありません でした 2,3。 参考文献 1 Boyer DS, et al. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017...